This compound is a synthetic peptide pharmaceutical raw material designed as an LHRH agonist. It consists of a decapeptide chain with multiple amino acid residues and is supplied as an acetate salt form suitable for research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing (Des-Gly10,D-Tyr5,D-Ser(tBu)6,Pro-NHEt9)-LHRH Acetate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
S-pantoprazole
pharmaceutical raw material
Cabazitaxel acetone
pharmaceutical raw material
Cessna LC-126
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
(Des-Gly10,D-His2,D-Ser(tBu)6,Pro-NHEt9)-LHRH Acetate
research compound
[1-(5-oxo-D-proline)]buserelin
pharmaceutical raw material
Buserelin EP Impurity B
pharmaceutical raw material
Buserelin
pharmaceutical raw material
acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
PYMDEDHDQYLBRT-OODYQVIQSA-N
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O
Sourcing (Des-Gly10,D-Tyr5,D-Ser(tBu)6,Pro-NHEt9)-LHRH Acetate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.